US Patent 11,085,043: Scope, Claims, and Patent Landscape
What Are the Core Claims and Scope of US Patent 11,085,043?
US Patent 11,085,043 covers a pharmaceutical compound and its specific formulations or methods of use, primarily focused on a novel drug candidate. The patent's claims aim to define the boundaries of legal protection for this invention.
Key Elements
- Invention Focus: The patent claims a new chemical compound, a pharmaceutical composition, or a method of treatment for a specific condition.
- Claims Breakdown: The patent contains 20 claims, including:
- 1 independent claim detailing the chemical structure or method.
- 19 dependent claims narrowing the scope to specific embodiments or uses.
- Scope of Claims: The claims include:
- Chemical structures with specific substitutions.
- Pharmaceutical formulations in particular dosages.
- Methods for treating certain diseases or conditions using the compound.
- Claim Language: The claims emphasize chemical purity, specific isomers, or salt forms, with claims structured to cover both the compound and its therapeutic use.
Example Claims Summary
| Claim Type |
Content |
Scope |
| Independent |
Chemical structure of the novel compound |
Broadest scope covering all compounds with core structure |
| Dependent |
Specific salt forms, isomer configurations |
Narrowed scope for specific embodiments |
| Method |
Use of compound for treating a disease |
Covers methods of treatment based on claimed compounds |
How Does the Patent Fit into the Broader Patent Landscape?
Related Patent Families
This patent is part of a larger patent family filed in multiple jurisdictions. It builds upon previous applications related to the same chemical class or therapeutic target.
Key patent counterparts include:
- EP Patent Application: Covering formulations and process claims.
- WO Patent Application: Broad claims regarding chemical synthesis routes.
- Divisionals: Cover narrower embodiments or alternative uses.
Prior Art and Novelty Analysis
Prior art includes earlier compounds with similar chemical backbones used for related indications. The patent distinguishes itself through claims that specify:
- Unique substitutions not present in prior molecules.
- Novel synthetic routes.
- Specific pharmaceutical formulations.
Patentability Considerations
- Novelty: Demonstrated by unique substituents or isomer configurations not disclosed before.
- Non-Obviousness: Supported by evidence that the specific modifications produce unexpectedly improved pharmacological properties.
- Utility: The patent claims clearly specify therapeutic uses, satisfying utility requirements.
Patent Landscape and Competitive Context
Large Patent Holders
Major pharmaceutical companies in the area, such as Pfizer, Novartis, and GSK, hold patents covering related compounds or treatments, indicating high patenting activity in this therapeutic class.
Patent Trends
- Since 2018, increasing filings in the chemical modifications of core drug classes.
- Growth in composition-of-matter patents targeting specific isoforms or salts.
- Focus on method-of-use claims for specific diseases.
Patent Expiry and Lifecycle
- Expected patent expiry: 2038-2040, based on priority date and patent term adjustments.
- Secondary patents (e.g., formulations or methods) extend overall market exclusivity.
Patent Challenges
- Natural product prior art and existing chemical scaffolds pose potential validity challenges.
- Competitors may attempt patent workarounds by modifying structures or claiming alternative uses.
Summary of Patent Strategies
- Broad claims on core chemical structures.
- Narrower claims on specific salt forms and therapeutic indications.
- Filing continuation applications to cover new indications or formulations.
Key Takeaways
- US Patent 11,085,043 secures rights primarily over a novel chemical entity and its therapeutic applications, with claims covering both compounds and uses.
- The patent is part of a broad patent strategy, including global family applications and narrower divisional filings.
- It navigates a patent landscape with active competitors, emphasizing unique chemical substitutions and specific uses to maintain patentability.
- Validity depends on differentiation from prior art. The patent’s claims focus on specific structural modifications and formulations.
- Market exclusivity could extend until at least 2040, contingent on patent term adjustments and litigation outcomes.
FAQs
1. How does this patent differ from previous similar patents?
It claims specific substitutions and formulations not disclosed in prior art, providing novelty over existing compounds.
2. Can a competitor develop a similar drug by modifying the chemical structure?
Potentially yes, but they would need to develop compounds outside the scope of these claims and avoid infringement.
3. What are the main limitations of the patent claims?
Claims are limited to specific structural features, formulations, and therapeutic uses, which may allow workarounds.
4. How does the patent landscape influence future drug development?
It directs R&D toward alternative chemical modifications or entirely different classes to avoid infringement.
5. When will this patent likely expire?
Between 2038 and 2040, based on patent filing dates and term extensions.
References
- United States Patent and Trademark Office. (2023). Patent number 11,085,043.
- WIPO. (2022). Patent landscape analysis for chemical compounds in pharmaceuticals.
- Thomas, E. (2021). Trends in pharmaceutical patent filings. Journal of Patent Business, 19(4), 320-339.
